Chemotherapy regimens (n = 446)
| Regimen . | No. of patients (%) . |
|---|---|
| Idarubicin + HD ara-C | 182 (41) |
| Idarubicin + HD ara-C + fludarabine | 99 (22) |
| Fludarabine + HD ara-C | 75 (17) |
| Topotecan + HD ara-C | 16 (4) |
| Topotecan + HD ara-C + cyclophosphamide | 48 (11) |
| Clofarabine + HD ara-C | 8 (2) |
| Miscellaneous + standard or HD ara-C | 18 (4) |
| Regimen . | No. of patients (%) . |
|---|---|
| Idarubicin + HD ara-C | 182 (41) |
| Idarubicin + HD ara-C + fludarabine | 99 (22) |
| Fludarabine + HD ara-C | 75 (17) |
| Topotecan + HD ara-C | 16 (4) |
| Topotecan + HD ara-C + cyclophosphamide | 48 (11) |
| Clofarabine + HD ara-C | 8 (2) |
| Miscellaneous + standard or HD ara-C | 18 (4) |
HD indicates high dose; and ara-C, cytarabine.